In this issue:
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment
Niraparib in newly diagnosed advanced ovarian cancer
Olaparib + bevacizumab as first-line maintenance in ovarian cancer
Veliparib with first-line chemotherapy and as maintenance therapy in ovarian cancer
Secondary surgical cytoreduction for recurrent ovarian cancer
Please login below to download this issue (PDF)